Climb Bio, Inc. (CLYM)
Pharmaceutical Preparations
Latest Price
$12.08
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
2.17
P/B Ratio
5.56
Institutional Ownership
66.0% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11.30M | $77.0M | 23.66% | +7.1K | 2026-03-31 |
| MPM BIOIMPACT LLC | 2.59M | $17.0M | 5.43% | -78.0K | 2026-03-31 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.92M | $13.0M | 4.01% | -6.7K | 2026-03-31 |
| BRAIDWELL LP | 1.53M | $10.0M | 3.20% | -- | 2026-03-31 |
| GREAT POINT PARTNERS LLC | 1.33M | $9.0M | 2.79% | +354.6K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 1.28M | $8.0M | 2.67% | +979.9K | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.18M | $8.0M | 2.47% | -- | 2026-03-31 |
| Kynam Capital Management, LP | 1.00M | $6.0M | 2.10% | -25.0K | 2026-03-31 |
| MARSHALL WACE, LLP | 773.1K | $5.0M | 1.62% | +469.1K | 2026-03-31 |
| Affinity Asset Advisors, LLC | 700.0K | $4.0M | 1.47% | -600.0K | 2026-03-31 |